CRIS Current Research Information System

AMBROSINI, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 10.742
NA - Nord America 10.681
EU - Europa 8.162
SA - Sud America 689
AF - Africa 554
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 30.842
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.562
VN - Vietnam 3.333
SG - Singapore 2.721
CN - Cina 2.677
GB - Regno Unito 2.008
DE - Germania 1.264
NL - Olanda 1.103
IT - Italia 884
HK - Hong Kong 703
SE - Svezia 639
FR - Francia 500
BR - Brasile 492
IN - India 469
RU - Federazione Russa 420
UA - Ucraina 368
IE - Irlanda 267
ZA - Sudafrica 189
JP - Giappone 171
KR - Corea 155
FI - Finlandia 148
EE - Estonia 119
CI - Costa d'Avorio 112
CH - Svizzera 106
TG - Togo 97
AR - Argentina 85
SC - Seychelles 66
PH - Filippine 65
BD - Bangladesh 61
AT - Austria 60
JO - Giordania 53
ES - Italia 51
CA - Canada 50
BG - Bulgaria 48
ID - Indonesia 46
IQ - Iraq 46
TR - Turchia 44
BE - Belgio 41
MX - Messico 41
NG - Nigeria 39
TH - Thailandia 39
PL - Polonia 36
IR - Iran 27
GR - Grecia 25
CO - Colombia 24
EC - Ecuador 24
PY - Paraguay 21
TW - Taiwan 21
PK - Pakistan 20
CL - Cile 15
HR - Croazia 15
LT - Lituania 14
UZ - Uzbekistan 14
MA - Marocco 13
MY - Malesia 13
SA - Arabia Saudita 12
AU - Australia 9
CZ - Repubblica Ceca 9
EG - Egitto 9
LB - Libano 9
VE - Venezuela 9
IL - Israele 7
PA - Panama 7
PE - Perù 7
AE - Emirati Arabi Uniti 6
DO - Repubblica Dominicana 6
BO - Bolivia 5
CR - Costa Rica 5
MD - Moldavia 5
RO - Romania 5
TN - Tunisia 5
UY - Uruguay 5
AL - Albania 4
BJ - Benin 4
DK - Danimarca 4
KE - Kenya 4
NP - Nepal 4
OM - Oman 4
TT - Trinidad e Tobago 4
CY - Cipro 3
DZ - Algeria 3
HU - Ungheria 3
JM - Giamaica 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MU - Mauritius 3
NO - Norvegia 3
PT - Portogallo 3
RS - Serbia 3
SM - San Marino 3
AO - Angola 2
AZ - Azerbaigian 2
ET - Etiopia 2
EU - Europa 2
KW - Kuwait 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BF - Burkina Faso 1
CG - Congo 1
Totale 30.824
Salva come PNG Salva come JPEG
Città #
Singapore 1.840
Southend 1.798
Fairfield 1.160
Ashburn 1.033
Chandler 735
Hong Kong 667
Kerkrade 648
Ho Chi Minh City 616
Woodbridge 543
Hanoi 518
Houston 513
Seattle 509
San Jose 486
Wilmington 478
Princeton 407
Frankfurt am Main 391
Cambridge 384
Dong Ket 384
Beijing 357
Eygelshoven 338
Santa Clara 323
Ann Arbor 276
Hefei 274
Dublin 267
Boardman 255
Lauterbourg 218
Jacksonville 217
Bologna 184
Nanjing 169
Westminster 160
Los Angeles 154
Padova 144
Tokyo 138
Seoul 130
Helsinki 124
Abidjan 112
Berlin 111
New York 101
Lomé 97
Bern 96
Buffalo 95
Dallas 95
Jinan 93
Shenyang 90
Da Nang 88
Haiphong 84
Guangzhou 78
Milan 77
Saint Petersburg 76
Hebei 66
Changsha 65
Redondo Beach 65
Redmond 62
São Paulo 62
Shanghai 58
Tianjin 58
Medford 56
Council Bluffs 54
Amman 53
Mülheim 51
San Diego 51
Johannesburg 50
Nanchang 50
Chicago 48
Turin 48
Zhengzhou 45
Bremen 44
Munich 40
Sofia 40
Abeokuta 35
Vienna 34
Dearborn 33
Brussels 32
Des Moines 32
Jiaxing 32
Nuremberg 32
Bengaluru 31
Hangzhou 31
Redwood City 30
Yubileyny 30
Falkenstein 27
Biên Hòa 26
Can Tho 26
Florence 26
Thái Nguyên 26
Wuhan 26
Falls Church 24
Haikou 24
London 24
Phoenix 24
Mahé 23
Quận Bình Thạnh 23
Shenzhen 21
Tongling 21
Baghdad 20
Columbus 20
Kuban 20
Olalla 20
Rio de Janeiro 20
Rome 20
Totale 20.010
Salva come PNG Salva come JPEG
Nome #
18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy 1.724
Merkel cell carcinoma: a prompt diagnosis to increase survival 658
68Ga-DOTATATE PET/CT interobserver agreement for neuroendocrine tumor assessment: Results of a prospective study on 50 patients 330
Radiomic analysis performed on 68Ga-DOTANOC PET/CT allows discriminating primary pancreatic neuroendocrine tumour grading 297
F-18 FDG PET/CT detects muscle involvement in Erdheim-Chester disease 267
A [68Ga]Ga-DOTANOC PET/CT radiomic model for non-invasive prediction of tumour grade in pancreatic neuroendocrine tumours 256
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. 255
18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature. 245
Comparing PET-derived semiquantitative parameters and radiomic features in discriminating G1 and G2 primary pancreatic neuroendocrine tumours in 68Ga-DOTANOC PET/CT 234
18F-FACBC Compared With 11C-Choline PET/CT in Patients With Biochemical Relapse After Radical Prostatectomy: A Prospective Study in 28 Patients. 224
(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. 224
Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy 222
68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results. 221
Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study 220
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. 214
68Ga-DOTANOC PET/CT Detects Multifocal Hepatocellular Carcinoma 214
Is surgery the best treatment for sporadic small (≤2 cm) non-functioning pancreatic neuroendocrine tumours? A single centre experience 208
(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy. 207
11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma. 204
18F-FDG PET/CT for the Assessment of Disease Extension and Activity in Patients With Sarcoidosis: Results of a Preliminary Prospective Study 204
Successful multidisciplinary clinical approach and molecular characterization by whole transcriptome sequencing of a cardiac myxofibrosarcoma: A case report 203
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma 199
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors. 198
18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin 196
68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET. 192
Discordant response to chemotherapy: An unusual pattern of fluoro-deoxy-D-glucose uptake in heavily pre-treated lymphoma patients 190
18f-fdg pet/ct for restaging gastric cancer after surgical resection 190
Radiomic analysis could allow detecting misassigned bioptic grading when discriminating G1 and G2 primary pancreatic neuroendocrine tumours imaged with 68Ga-DOTANOC PET/CT 190
18F-FDG PET/CT detects systemic involvement in Sarcoidosis 188
11C-Choline PET/CT in patients with biochemical relapse after radical prostatectomy and PSA levels < 0.5 ng/mL 187
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms 186
Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results 185
Comparison between (68)Ga-DOTA-NOC and (18)F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. 184
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis 184
The additional diagnostic value of contemporary evaluation of FDG PET/CT scan and contrast enhanced CT imaging both acquired by a last generation PET/CT system in oncologic patients. 183
G1/G2 discrimination of pNET with [68Ga]Ga-DOTANOC PET/CT quantitative parameters: is it feasible? 183
68Ga-DOTA-NOC PET/CT detects somatostatin receptors expression in von hippel-lindau cerebellar disease. 182
Assessment of a chemically induced model of lung squamous cell carcinoma in mice by 18F-FDG small-animal PET. 182
Incidental diagnosis of very small rectal neuroendocrine neoplasms: when should endoscopic submucosal dissection be performed? A single ENETS centre experience 182
18F-FLT PET/CT in patients with advanced Non-Small Lung Cancer (NSCLC) treated with Nivolumab: preliminary results 181
A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience 179
Colon Sarcoidosis Mimicking Cancer at 18F-FDG PET/CT 174
New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms 173
Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update 172
Additional value of hybrid PET/CT fusion imaging vs. conventional CT scan alone in the staging and management of patients with malignant pleural mesothelioma 172
68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results. 171
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy? 171
Treatment of advanced gastro‐entero‐pancreatic neuro‐ endocrine tumors: A systematic review and network meta‐analysis of phase iii randomized controlled trials 170
Evaluation of unusual neuroendocrine tumours by means of (68)Ga-DOTA-NOC PET. 169
Preliminary evaluation of 68Ga-DOTA-NOC PET/CT in patients with idiopathic pulmonary fibrosis 168
68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid. 168
Cardiac FDG PET/CT to Assess the Culprit Lesion during Acute Infarction 168
Analisi in vitro ed in vivo dell'attività anti-tumorale dopo inibizione specifica di MYCN mediante PNA-NLS anti-gene nel rabdomiosarcoma umano 166
Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 Patients 165
Comparison between 18F-FDG PET/CT and 11C-Choline PET/CT for the evaluation of multiple myeloma 165
Is radical surgery always curative in pancreatic neuroendocrine tumors? A cure model survival analysis 165
Late FDG PET normalization after radioimmunotherapy in a patient with non-Hodgkin lymphoma. 163
Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy. Review 162
Case Report: The Complete Remission of a Mixed Germ Cell Tumor With Somatic Type Malignancy of Sarcoma Type With a GCT-Oriented Therapy: Clinical Findings and Genomic Profiling 162
[68Ga]Ga-DOTANOC Uptake at Pancreatic Head/Uncinate Process: Is It a Persistent Diagnostic Pitfall Over Time? 161
18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone. 161
68Ga DOTANOC PET/CT Detects Primary Malignant Insulinoma. 161
Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET. 160
111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging. 160
TÉCNICAS DE MEDICINA NUCLEAR EN LA VALORACIÓN DE LOS TUMORES NEUROENDOCRINOS 157
Focal lung uptake of 18F-fluorodeoxyglucose (18F-FDG) without computed tomography findings. 157
Validation of the 2010 WHO classification and a new prognostic proposal: A single centre retrospective study of well-differentiated pancreatic neuroendocrine tumours 157
(18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging. 155
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours 154
Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies. 152
Incidental finding of an (11)C-choline PET-positive solitary plasmacytoma lesion. 152
Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST-segment elevation myocardial infarction (NSTEMI). 152
Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis 151
Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE. 149
Preliminary results of the Italian FOLCETUX study: early evaluation of treatment response with 18FDG PET in gastric or gastroesophageal junction adenocarcinoma. 148
Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors. 148
Radiomic Model Discriminating Low Grade Pancreatic Neuroendocrine Tumours Assessed by Biopsy of the Primary Lesion 147
Osteoblastic bone response mimicking bone progression during treatment with pembrolizumab in advanced cutaneous melanoma 145
Comparison of Different Positron Emission Tomography Tracers in Patients with Recurrent Medullary Thyroid Carcinoma: Our Experience and a Review of the Literature 144
Molecular Imaging of Neuroblastoma Progression in TH-MYCN Transgenic Mice 144
Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? 144
Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors 144
18[F]FDG small animal PET study of sorafenib efficacy in lymphoma preclinical models. 143
Small animal PET for the evaluation of an animal model of genital infection 143
Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers 142
A new dimension of FDG-PET interpretation: assessment of tumor biology. 142
FDG small animal PET permits early detection of malignant cells in a xenograft murine model. 142
[68Ga]Ga-DOTANOC PETICT & radiomics: Potential role in discriminating tumor grade in well-differentiated primary pancreatic neuroendocrine tumors 142
Two birds with one stone: can [68Ga]Ga-DOTANOC PET/CT image quality be improved through BMI-adjusted injected activity without increasing acquisition times? 141
18F-FDG PET/CT impact on testicular tumours clinical management 141
Sporadic Small (≤20 mm) Nonfunctioning Pancreatic Neuroendocrine Neoplasm: is the Risk of Malignancy Negligible When Adopting a More Conservative Strategy? A Systematic Review and Meta-analysis 139
Performance evaluation of a small animal PET scanner. Spatial resolution characterization using F-18 and C-11. 139
Pitfalls in oncology: Osteoblastic response mimicking bone progression during ceritinib treatment in ALK-rearranged NSCLC 138
[68Ga]Ga-DOTANOC PET/CT Derived Radiomic Features Can Discriminate Pancreatic Neuroendocrine Tumours from Accessory Spleens: Preliminary Results 138
FDG-PET in the serial assessment of patinets with lymphoma in complete remission 137
Is there an ideal diagnostic algorithm in solitary pulmonary nodules? 136
Usefulness of FDG-PET in detection of local and distant recurrent cervical cancer in symptomatic women 136
Multimodal strategy in localized merkel cell carcinoma: Where are we and where are we heading? 136
Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF 135
Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT. 134
Totale 19.603
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.597
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.597
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.086 0 0 0 0 0 0 0 0 0 137 170 779
2021/20223.781 846 112 204 222 298 178 55 252 140 138 818 518
2022/20233.481 385 509 207 435 211 245 100 183 563 189 265 189
2023/2024885 96 159 40 77 72 167 53 56 34 61 35 35
2024/20254.052 144 648 350 254 626 210 512 94 48 191 199 776
2025/202610.683 755 1.313 874 722 1.086 1.540 1.331 450 1.974 638 0 0
Totale 31.340